American Healthcare REIT Inc.

AHR | NYSE

Price Alert Chart Builder DCF Calculator

$53.52

+$0.58 (+1.10%)

At close: Oct 30, 2026, 4:00 PM ET

$53.52

$0.00 (0.00%)

After-hours: Oct 30, 2026, 4:00 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Market Data

Market Cap $11.65B

Enterprise Value $13.06B

Beta 0.80

Average Volume 3.33M

Shares Outstanding (Diluted) 190.71M

Shares Change YoY 18.35%

Institutional Ownership N/A

Exchange NYSE

ISIN US3981823038

Price Performance

Price Change 1M 4.4%

Price Change 3M -3.7%

Price Change 6M 6.7%

Price Change YTD 13.7%

Price Change 1Y 18.1%

Price Change 3Y N/A

Price Change 5Y N/A

1M CAGR (ann.) 3.1%

1Y CAGR (ann.) 22.6%

5Y CAGR (ann.) N/A

All-Time CAGR 72.8%

Valuation

PE Ratio 78.71

Forward PE 88.94

PEG Ratio 0.07

Forward PEG 4.87

PS Ratio 4.65

Forward PS 3.70

PB Ratio 3.15

P/FCF Ratio 44.48

P/Adj. FCF Ratio 48.06

P/OCF Ratio 27.59

EV/Sales 5.22

EV/EBIT 74.12

EV/EBITDA 28.62

EV/FCF 49.87

Earnings Yield 1.3%

FCF Yield 2.3%

Adj. FCF Yield 2.1%

Financial Health

Net Debt $1.29B

Total Debt $1.57B

Cash & Short-Term Investments $156.9M

Total Assets $5.7B

Current Ratio 0.18

Quick Ratio 0.18

Debt / Equity Ratio 0.42

Debt / EBITDA 3.44

Debt / FCF 5.99

OCF / Debt 0.24

Interest Coverage 2.17

Altman Z-Score 3.56

Piotroski F-Score 5

Margins & Profitability

Gross Profit Margin 14.9%

Operating Profit Margin 6.7%

EBITDA Margin 18.2%

Net Profit Margin 4.8%

FCF Margin 10.5%

Adj. FCF Margin 9.7%

SBC / Revenue 0.8%

SBC Impact (per share) -7.4%

Returns

Return on Assets 2.1%

Return on Equity 3.7%

Return on Invested Capital 3.1%

Return on Capital Employed 3.5%

Return on Tangible Assets 2.3%

Historical Growth (CAGR)

Revenue CAGR 3Y 12.0%

Revenue CAGR 5Y 13.8%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 2592.9%

EPS CAGR 5Y 66.6%

EPS CAGR 10Y N/A

FCF CAGR 3Y 77.0%

FCF CAGR 5Y 12.8%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 9

EPS Growth Next 3Y 17.7%

Revenue Growth Next 3Y 15.7%

Earnings Date Nov 5, 2026

EPS Estimate (next Q) $0.15

EPS Growth Est (next Q) -53.4%

Revenue Est (next Q) $703.51M

Revenue Growth Est (next Q) 22.8%

Fair Value Estimates

Graham Number $17.36

Graham Upside -67.6%

Lynch Fair Value $17.00

Lynch Upside -68.2%

Price Target $63.63

Price Target Upside 18.9%

Cash Flow

Operating Cash Flow $369.03M

Free Cash Flow $261.84M

Adj. Free Cash Flow $242.34M

FCF Per Share $1.38

OCF Per Share $1.94

OCF/S Ratio 14.7%

Income Statement

Revenue $2.5B

Gross Profit $373.79M

Operating Income $168.67M

EBITDA $456.23M

Net Income $121.02M

EPS (Diluted) $0.68

Revenue / Employee $20.68M

Profit / Employee $1M

Employees 121

Dividends

Annual Dividend $1.00

Dividend Yield 1.87%

Payout Ratio 147.1%

FCF Payout Ratio 68.2%

Adj. FCF Payout Ratio 73.7%

Dividend Growth (YoY) 0.0%

Pay Frequency Quarterly

Ex-Dividend Date Sep 30, 2026